BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Munier FL, Beck-Popovic M, Chantada GL, Cobrinik D, Kivelä TT, Lohmann D, Maeder P, Moll AC, Carcaboso AM, Moulin A, Schaiquevich P, Bergin C, Dyson PJ, Houghton S, Puccinelli F, Vial Y, Gaillard MC, Stathopoulos C. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity". Prog Retin Eye Res 2019;73:100764. [PMID: 31173880 DOI: 10.1016/j.preteyeres.2019.05.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 López-Malo D, Villarón-Casares CA, Alarcón-Jiménez J, Miranda M, Díaz-Llopis M, Romero FJ, Villar VM. Curcumin as a Therapeutic Option in Retinal Diseases. Antioxidants (Basel) 2020;9:E48. [PMID: 31935797 DOI: 10.3390/antiox9010048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
2 Wang L, Zhang Y, Xin X. Long non-coding RNA MALAT1 aggravates human retinoblastoma by sponging miR-20b-5p to upregulate STAT3. Pathol Res Pract 2020;216:152977. [PMID: 32336590 DOI: 10.1016/j.prp.2020.152977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Reddy MA, Butt M, Hinds AM, Duncan C, Price EA, Sagoo MS, Onadim Z. Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic). Ophthalmol Retina 2021;5:381-7. [PMID: 32835838 DOI: 10.1016/j.oret.2020.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cancela MB, Zugbi S, Winter U, Martinez AL, Sampor C, Sgroi M, Francis JH, Garippa R, Abramson DH, Chantada G, Schaiquevich P. A decision process for drug discovery in retinoblastoma. Invest New Drugs 2021;39:426-41. [PMID: 33200242 DOI: 10.1007/s10637-020-01030-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Biancalana L, Batchelor LK, Pereira SAP, Tseng P, Zacchini S, Pampaloni G, Saraiva LMFS, Dyson PJ, Marchetti F. Bis‐conjugation of Bioactive Molecules to Cisplatin‐like Complexes through (2,2′‐Bipyridine)‐4,4′‐Dicarboxylic Acid with Optimal Cytotoxicity Profile Provided by the Combination Ethacrynic Acid/Flurbiprofen. Chem Eur J 2020;26:17525-35. [DOI: 10.1002/chem.202003199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, Zhao J, Wilson MW, Brennan RC, Burges M, Kim J, Berry JL, Jubran R, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Volodin D, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-ortiz MA, Esparza-aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català-mora J, Correa-llano G, Carreras E. Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-based Study. Ophthalmology 2022. [DOI: 10.1016/j.ophtha.2022.04.022] [Reference Citation Analysis]
7 Aschero R, Francis JH, Ganiewich D, Gomez-Gonzalez S, Sampor C, Zugbi S, Ottaviani D, Lemelle L, Mena M, Winter U, Correa Llano G, Lamas G, Lubieniecki F, Szijan I, Mora J, Podhajcer O, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lavarino C, Chantada GL. Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma. Cancers (Basel) 2021;13:673. [PMID: 33567541 DOI: 10.3390/cancers13040673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li F, Xia Q, Ren L, Nie Y, Ren H, Guo X, Yu J, Xing Y, Chen Z, Rai SN. GSDME Increases Chemotherapeutic Drug Sensitivity by Inducing Pyroptosis in Retinoblastoma Cells. Oxidative Medicine and Cellular Longevity 2022;2022:1-29. [DOI: 10.1155/2022/2371807] [Reference Citation Analysis]
9 Steiner B, Ritter-sovinz P, Steltner B, Benesch M, Wedrich A, Deutschmann H, Schwab C. Retinoblastom Report Österreich 2020. Spektrum Augenheilkd . [DOI: 10.1007/s00717-021-00514-5] [Reference Citation Analysis]
10 Berry JL, Munier FL, Gallie BL, Polski A, Shah S, Shields CL, Gombos DS, Ruchalski K, Stathopoulos C, Shah R, Jubran R, Kim JW, Mruthyunjaya P, Marr BP, Wilson MW, Brennan RC, Chantada GL, Chintagumpala MM, Murphree AL. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatr Blood Cancer 2021;68:e28964. [PMID: 33624399 DOI: 10.1002/pbc.28964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hobzova R, Kodetova M, Pochop P, Uhlik J, Dunovska K, Svojgr K, Hrabeta J, Feriancikova B, Cocarta AI, Sirc J. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model. Int J Pharm 2021;606:120832. [PMID: 34175379 DOI: 10.1016/j.ijpharm.2021.120832] [Reference Citation Analysis]
12 Zugbi S, Ganiewich D, Bhattacharyya A, Aschero R, Ottaviani D, Sampor C, Cafferata EG, Mena M, Sgroi M, Winter U, Lamas G, Suñol M, Daroqui M, Baialardo E, Salas B, Das A, Fandiño A, Francis JH, Lubieniecki F, Lavarino C, Garippa R, Podhajcer OL, Abramson DH, Radvanyi F, Chantada G, Llera AS, Schaiquevich P. Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers (Basel) 2020;12:E2714. [PMID: 32971811 DOI: 10.3390/cancers12092714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Finger PT, Tomar AS. Retinoblastoma outcomes: a global perspective. The Lancet Global Health 2022. [DOI: 10.1016/s2214-109x(21)00598-2] [Reference Citation Analysis]
14 Stathopoulos C, Lumbroso-Le Rouic L, Moll AC, Parulekar M, Maeder P, Doz F, Jenkinson H, Beck Popovic M, Chantada G, Munier FL. Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel) 2021;13:3392. [PMID: 34298608 DOI: 10.3390/cancers13143392] [Reference Citation Analysis]
15 Zhou M, Wen X, Jia S, Han Y, He X, Han M, Xu W, Fan J, Jia R, Fan X. Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy. Br J Ophthalmol 2021:bjophthalmol-2021-319118. [PMID: 34039564 DOI: 10.1136/bjophthalmol-2021-319118] [Reference Citation Analysis]
16 Liu J, Ottaviani D, Sefta M, Desbrousses C, Chapeaublanc E, Aschero R, Sirab N, Lubieniecki F, Lamas G, Tonon L, Dehainault C, Hua C, Fréneaux P, Reichman S, Karboul N, Biton A, Mirabal-Ortega L, Larcher M, Brulard C, Arrufat S, Nicolas A, Elarouci N, Popova T, Némati F, Decaudin D, Gentien D, Baulande S, Mariani O, Dufour F, Guibert S, Vallot C, Rouic LL, Matet A, Desjardins L, Pascual-Pasto G, Suñol M, Catala-Mora J, Llano GC, Couturier J, Barillot E, Schaiquevich P, Gauthier-Villars M, Stoppa-Lyonnet D, Golmard L, Houdayer C, Brisse H, Bernard-Pierrot I, Letouzé E, Viari A, Saule S, Sastre-Garau X, Doz F, Carcaboso AM, Cassoux N, Pouponnot C, Goureau O, Chantada G, de Reyniès A, Aerts I, Radvanyi F. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat Commun 2021;12:5578. [PMID: 34552068 DOI: 10.1038/s41467-021-25792-0] [Reference Citation Analysis]
17 Chai P, Jia R, Li Y, Zhou C, Gu X, Yang L, Shi H, Tian H, Lin H, Yu J, Zhuang A, Ge S, Jia R, Fan X. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Prog Retin Eye Res 2021;:101030. [PMID: 34861419 DOI: 10.1016/j.preteyeres.2021.101030] [Reference Citation Analysis]
18 Yousef YA, Mohammad M, Mehyar M, Sultan I, Al-Hussaini M, Alhourani J, Halalsheh H, Khzouz J, Jaradat I, Qaddoumi I, Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. J Pediatr Hematol Oncol 2021;43:e841-7. [PMID: 33769386 DOI: 10.1097/MPH.0000000000002144] [Reference Citation Analysis]
19 Kaewkhaw R, Rojanaporn D. Retinoblastoma: Etiology, Modeling, and Treatment. Cancers (Basel) 2020;12:E2304. [PMID: 32824373 DOI: 10.3390/cancers12082304] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
20 Le Gall J, Dehainault C, Benoist C, Matet A, Lumbroso-Le Rouic L, Aerts I, Jiménez I, Schleiermacher G, Houdayer C, Radvanyi F, Frouin E, Renault V, Doz F, Stoppa-Lyonnet D, Gauthier-Villars M, Cassoux N, Golmard L. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. J Mol Diagn 2021;23:1714-21. [PMID: 34656762 DOI: 10.1016/j.jmoldx.2021.08.014] [Reference Citation Analysis]
21 Gerrish A, Jenkinson H, Cole T. The Impact of Cell-Free DNA Analysis on the Management of Retinoblastoma. Cancers (Basel) 2021;13:1570. [PMID: 33805427 DOI: 10.3390/cancers13071570] [Reference Citation Analysis]
22 Yang M, Li Y, Wei W. MicroRNA-188-5p Promotes Epithelial-Mesenchymal Transition by Targeting ID4 Through Wnt/β‑catenin Signaling in Retinoblastoma. Onco Targets Ther 2019;12:10251-62. [PMID: 31819510 DOI: 10.2147/OTT.S229739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
23 Schefler AC, Kim RS. Recent advancements in the management of retinoblastoma and uveal melanoma. Fac Rev 2021;10:51. [PMID: 34195690 DOI: 10.12703/r/10-51] [Reference Citation Analysis]
24 Bossacoma F, Cuadrado-Vilanova M, Vinent J, Correa MG, Gavrus D, Castillo-Ecija H, Catala-Mora J, Mora J, Schaiquevich P, Chantada GL, Carcaboso AM. Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection. Ophthalmic Genet 2020;41:397-400. [PMID: 32490703 DOI: 10.1080/13816810.2020.1776336] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Gerrish A, Bowns B, Mashayamombe-Wolfgarten C, Young E, Court S, Bott J, McCalla M, Ramsden S, Parks M, Goudie D, Carless S, Clokie S, Cole T, Allen S. Non-Invasive Prenatal Diagnosis of Retinoblastoma Inheritance by Combined Targeted Sequencing Strategies. J Clin Med 2020;9:E3517. [PMID: 33143217 DOI: 10.3390/jcm9113517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Rojanaporn D, Attaseth T, Dieosuthichat W, Leelawongs K, Pakakasama S, Anurathapan U, Chanthanaphak E, Singhara Na Ayudhaya S, Aroonroch R, Hongeng S. Clinical Presentations and Outcomes of Retinoblastoma Patients in relation to the Advent of New Multimodal Treatments: A 12-Year Report from Single Tertiary Referral Institute in Thailand. J Ophthalmol 2020;2020:4231841. [PMID: 33005446 DOI: 10.1155/2020/4231841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 van Hoefen Wijsard M, Serné SH, Otten RH, Bosscha MI, Dommering CJ, Fabius AW, Moll AC. At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review. Cancers (Basel) 2021;13:1942. [PMID: 33920538 DOI: 10.3390/cancers13081942] [Reference Citation Analysis]
28 Luo Y, Zhou C, He F, Fan J, Wen X, Ding Y, Han Y, Ding J, Jin M, Liu Z, Wang S, Han M, Yuan H, Sun H, Xiao Y, Wu L, Wang J, Li Y, Yang H, Yu J, Gong J, Xu Y, Wen Y, Gao Z, Mei L, Ye J, Liu H, Chen Z, Xue S, Liu R, Chen H, Lu W, Liao H, Guo Q, Cui J, Zhu D, Lu F, Tang S, Wu Y, Yangkyi T, Guanghong Z, Wubuli M, Huiyu G, Wang X, He Y, Sheng X, Wang Q, Tan J, Liang J, Sun X, Zhang J, Ji X, Jin L, Zhao J, Yang X, Jia R, Fan X. Contemporary update of retinoblastoma in China: Three-decade changes in epidemiology, clinical features, treatments and outcomes. Am J Ophthalmol 2021:S0002-9394(21)00498-0. [PMID: 34626572 DOI: 10.1016/j.ajo.2021.09.026] [Reference Citation Analysis]
29 Kodetova M, Hobzova R, Sirc J, Uhlik J, Dunovska K, Svojgr K, Cocarta A, Felsoova A, Slanar O, Sima M, Kozak I, Pochop P. The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant. Pharmaceutics 2022;14:903. [DOI: 10.3390/pharmaceutics14050903] [Reference Citation Analysis]
30 Gudiseva HV, Berry JL, Polski A, Tummina SJ, O'Brien JM. Next-Generation Technologies and Strategies for the Management of Retinoblastoma. Genes (Basel). 2019;10:1032. [PMID: 31835688 DOI: 10.3390/genes10121032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
31 Del Carmen Bernal-Díaz Z, Murillo-Maldonado MA, Pérez-Villanueva H, Reyes-López A, Ramírez-Ortiz MA. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital. Pediatr Blood Cancer 2020;67:e28625. [PMID: 32743978 DOI: 10.1002/pbc.28625] [Reference Citation Analysis]
32 Stathopoulos C, Bartolini B, Marie G, Beck-Popovic M, Saliou G, Munier FL. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach. Ophthalmology 2021;128:754-64. [PMID: 32956742 DOI: 10.1016/j.ophtha.2020.09.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Jia S, Wen X, Zhou M, He X, Han M, Fan J, Jia R, Fan X. Comparison of Intra-Arterial Chemotherapy Efficacy Delivered Through the Ophthalmic Artery or External Carotid Artery in a Cohort of Retinoblastoma Patients. Front Med (Lausanne) 2021;8:658305. [PMID: 34179043 DOI: 10.3389/fmed.2021.658305] [Reference Citation Analysis]
34 Gerste RD. Contributions to Progress in Ophthalmology from Switzerland: From the 16th to the 21st Century. Ophthalmologica 2021;244:1-17. [PMID: 32836218 DOI: 10.1159/000511057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Jansen RW, de Bloeme CM, Brisse HJ, Galluzzi P, Cardoen L, Göricke S, Maeder P, Cassoux N, Gauthier A, Schlueter S, Hadjistilianou T, Munier FL, Castelijns JA, van der Valk P, Moll AC, de Jong MC, de Graaf P. MR Imaging Features to Differentiate Retinoblastoma from Coats' Disease and Persistent Fetal Vasculature. Cancers (Basel) 2020;12:E3592. [PMID: 33266342 DOI: 10.3390/cancers12123592] [Reference Citation Analysis]
36 Dräger O, Metz K, Busch M, Dünker N. Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets. Mol Oncol 2021. [PMID: 34228897 DOI: 10.1002/1878-0261.13054] [Reference Citation Analysis]
37 Soliman SE, Bansal A, De Nicola ML, Bhambhwani V, Laperriere N, Gallie BL, Krema H. Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma. Can J Ophthalmol 2021:S0008-4182(21)00001-6. [PMID: 33493457 DOI: 10.1016/j.jcjo.2020.12.016] [Reference Citation Analysis]
38 Jiang Y, Xiao F, Wang L, Wang T, Chen L. Hsa_circ_0099198 facilitates the progression of retinoblastoma by regulating miR-1287/LRP6 axis. Exp Eye Res 2021;206:108529. [PMID: 33676964 DOI: 10.1016/j.exer.2021.108529] [Reference Citation Analysis]
39 Gu X, Xie M, Jia R, Ge S. Publication Trends of Research on Retinoblastoma During 2001-2021: A 20-Year Bibliometric Analysis. Front Med (Lausanne) 2021;8:675703. [PMID: 34095180 DOI: 10.3389/fmed.2021.675703] [Reference Citation Analysis]
40 Xu L, Kim ME, Polski A, Prabakar RK, Shen L, Peng CC, Reid MW, Chévez-Barrios P, Kim JW, Shah R, Jubran R, Kuhn P, Cobrinik D, Biegel JA, Gai X, Hicks J, Berry JL. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers (Basel) 2021;13:1282. [PMID: 33805776 DOI: 10.3390/cancers13061282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Liu W, Luo Y, Dai J, Yang L, Huang L, Wang R, Chen W, Huang Y, Sun S, Cao J, Wu J, Han M, Fan J, He M, Qian K, Fan X, Jia R. Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting. Small Methods 2022;6:e2101220. [PMID: 35041286 DOI: 10.1002/smtd.202101220] [Reference Citation Analysis]
42 Moulay Lakhdar I, Ferlazzo ML, Al Choboq J, Berthel E, Sonzogni L, Devic C, Granzotto A, Thariat J, Foray N. Fibroblasts from Retinoblastoma Patients Show Radiosensitivity Linked to Abnormal Localization of the ATM Protein. Curr Eye Res 2021;46:546-57. [PMID: 32862699 DOI: 10.1080/02713683.2020.1808998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Fabius AWM, van Hoefen Wijsard M, van Leeuwen FE, Moll AC. Subsequent Malignant Neoplasms in Retinoblastoma Survivors. Cancers (Basel) 2021;13:1200. [PMID: 33801943 DOI: 10.3390/cancers13061200] [Reference Citation Analysis]
44 Tomar AS, Finger PT, Gallie B, Mallipatna A, Kivelä TT, Zhang C, Zhao J, Wilson MW, Brenna RC, Burges M, Kim J, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català J, Correa-Llano G, Carreras E; American Joint Committee on Cancer Ophthalmic Oncology Task Force. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage. Ophthalmology 2020;127:1733-46. [PMID: 32526306 DOI: 10.1016/j.ophtha.2020.05.051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
45 Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, Zhao J, Wilson MW, Brenna RC, Burges M, Kim J, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català J, Correa-Llano G, Carreras E; American Joint Committee on Cancer Ophthalmic Oncology Task Force. Global Retinoblastoma Treatment Outcomes: Association with National Income Level. Ophthalmology 2021;128:740-53. [PMID: 33007338 DOI: 10.1016/j.ophtha.2020.09.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Cobbs LV, Francis JH, Dunkel IJ, Gobin YP, Brodie SE, Abramson DH. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions. Pediatr Blood Cancer 2021;68:e28845. [PMID: 33355996 DOI: 10.1002/pbc.28845] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 van Hoefen Wijsard M, Schonfeld SJ, van Leeuwen FE, Moll AC, Fabius AW, Abramson DH, Seddon JM, Francis JH, Tucker MA, Kleinerman RA, Morton LM. Benign Tumors in Long-Term Survivors of Retinoblastoma. Cancers (Basel) 2021;13:1773. [PMID: 33917779 DOI: 10.3390/cancers13081773] [Reference Citation Analysis]
48 Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: A 2020 review. Indian J Ophthalmol 2020;68:2356-65. [PMID: 33120616 DOI: 10.4103/ijo.IJO_721_20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
49 Warda O, Naeem Z, Roelofs KA, Sagoo MS, Reddy MA. Retinoblastoma and vision. Eye (Lond) 2022. [PMID: 34987197 DOI: 10.1038/s41433-021-01845-y] [Reference Citation Analysis]
50 Biewald E, Kiefer T, Geismar D, Schlüter S, Manthey A, Westekemper H, Wulff J, Timmermann B, Ketteler P, Schönberger S, Metz KA, Ting S, Göricke S, Bechrakis NE, Bornfeld N. Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes. Cancers (Basel) 2021;13:1862. [PMID: 33924716 DOI: 10.3390/cancers13081862] [Reference Citation Analysis]
51 Shi K, Zhu X, Wu J, Chen Y, Zhang J, Sun X. Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma. Bioengineered 2021;12:5950-70. [PMID: 34482803 DOI: 10.1080/21655979.2021.1972080] [Reference Citation Analysis]
52 Schaiquevich P, Francis JH, Cancela MB, Carcaboso AM, Chantada GL, Abramson DH. Treatment of Retinoblastoma: What Is the Latest and What Is the Future. Front Oncol 2022;12:822330. [DOI: 10.3389/fonc.2022.822330] [Reference Citation Analysis]
53 Li L, He T, Su Y, Wu L, Chen C. The Results of Pars Plana Vitrectomy in the Treatment of Intraocular Retinoblastoma: A Retrospective Study and Literature Review. Technol Cancer Res Treat 2021;20:15330338211048634. [PMID: 34747279 DOI: 10.1177/15330338211048634] [Reference Citation Analysis]
54 González ME, Gaviria ML, López M, Escudero PA, Bravo A, Vargas SA. Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia. Ocul Oncol Pathol 2021;7:215-23. [PMID: 34307335 DOI: 10.1159/000511980] [Reference Citation Analysis]